Insights

Global Market Penetration Adalvo has a strong presence across more than 15 countries and partnerships with over 140 commercial partners worldwide, representing significant opportunity for expanding sales in diverse geographic regions and leveraging its established distribution channels.

Recent Product Launches The company's recent launches of high-demand products such as Rivaroxaban, Dapagliflozin, and Adapalene/Benzoyl Peroxide across multiple markets demonstrate its active new product pipeline, offering opportunities to introduce complementary therapies or expand into related therapeutic areas.

Focus on Key Markets Adalvo’s targeted launches in strategic markets like the UK, Europe, Asia, and North America highlight its ability to adapt to various regional regulations and customer needs, creating opportunities for localized sales efforts and tailored offerings.

Innovative and Differentiated Portfolio With a focus on differentiated, high-quality pharmaceutical products such as nasal sprays, PR formulations, and diabetes treatments, there is potential to upsell or introduce new formulations to existing partners and open new segments within the healthcare sector.

Partnership and Acquisition Potential Given its recent acquisition interest by EQT AB and its reputation as a reliable B2B partner, there are opportunities to position additional strategic collaborations or acquisitions targeting markets with high growth potential, increasing sales and market share.

Adalvo Tech Stack

Adalvo uses 8 technology products and services including Amazon S3, Open Graph, Cookiebot, and more. Explore Adalvo's tech stack below.

  • Amazon S3
    Content Delivery Network
  • Open Graph
    Content Management System
  • Cookiebot
    Cookie Compliance
  • Webpack
    Development
  • Microsoft Excel
    Editors
  • dc.js
    Javascript Graphics
  • Microsoft Azure
    Platform As A Service
  • CSS
    Web Tools And Plugins

Media & News

Adalvo's Email Address Formats

Adalvo uses at least 1 format(s):
Adalvo Email FormatsExamplePercentage
First.Last@adalvo.comJohn.Doe@adalvo.com
48%
Last.First@adalvo.comDoe.John@adalvo.com
2%
First.Last@adalvo.comJohn.Doe@adalvo.com
48%
Last.First@adalvo.comDoe.John@adalvo.com
2%

Frequently Asked Questions

What is Adalvo's official website and social media links?

Minus sign iconPlus sign icon
Adalvo's official website is adalvo.com and has social profiles on LinkedIn.

What is Adalvo's NAICS code?

Minus sign iconPlus sign icon
Adalvo's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Adalvo have currently?

Minus sign iconPlus sign icon
As of December 2025, Adalvo has approximately 254 employees across 3 continents, including EuropeAsiaSouth America. Key team members include Chief Operations Officer: A. K.Chief Intellectual Property Officer: T. S.Chief Financial Officer: M. D.. Explore Adalvo's employee directory with LeadIQ.

What industry does Adalvo belong to?

Minus sign iconPlus sign icon
Adalvo operates in the Pharmaceutical Manufacturing industry.

What technology does Adalvo use?

Minus sign iconPlus sign icon
Adalvo's tech stack includes Amazon S3Open GraphCookiebotWebpackMicrosoft Exceldc.jsMicrosoft AzureCSS.

What is Adalvo's email format?

Minus sign iconPlus sign icon
Adalvo's email format typically follows the pattern of First.Last@adalvo.com. Find more Adalvo email formats with LeadIQ.

When was Adalvo founded?

Minus sign iconPlus sign icon
Adalvo was founded in 2020.

Adalvo

Pharmaceutical ManufacturingSan Ġwann, Malta201-500 Employees

Adalvo is a global pharmaceutical company, and one of the leading B2B pharmaceutical companies in Europe, with commercial partnerships in more than 100 countries and for over 140 commercial partners globally. The company’s declared purpose is to make a difference for patients all over the world, driven by our smart collaboration network and commitment to delivering highest quality differentiated products and services to our partners. With headquarters in Malta, the company presence in more than 15 countries such as Switzerland, UK, Netherlands, Spain, Iceland, Austria, Romania, Hungary, Bulgaria, Turkey, Italy, Czech Republic, Uruguay, Slovenia and India. At Adalvo, we know that our partners like to be bigger, better and smarter in the dynamic pharmaceutical sector. That’s why our approach is unique, customized to our partners, and is designed to challenge the status quo: together, this helps our partners achieve their business goals. We take pride in our ability to help its partners reach their goals – be those increasing revenues or pushing into new markets. While partners are a high priority, Adalvo is also committed to its purpose and mission to accelerate the growth and development of employees and local communities. Adalvo tirelessly strives for excellence in all of its endeavours, driven by a deep-rooted passion to making a difference for partners. The company’s purpose driven culture is committed to improving the lives of patients around the world. Our dynamic leadership team brings significant experience and industry know-how to Adalvo, which has helped to establish the company as a reliable global partner.

Section iconCompany Overview

Website
adalvo.com
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2020
Employees
201-500

Section iconFunding & Financials

  • $500M$1B

    Adalvo's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $500M$1B

    Adalvo's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.